CHEK2 and ovarian carcinoma: Genotyping of 21 mutations in BRCA1, BRCA2, RAD51C, PALB2, and CHEK2 genes was performed for 102 BOT patients, 167 cases of ovarian cancer G1, and 1743 healthy controls.